Non-Hodgkin's Lymphoma - Treatment Options, Symptoms, Causes & Diagnosis from MedifocusHealth

Non-Hodgkin's Lymphoma > What Your Doctor is Reading About Non-Hodgkin's Lymphoma > General Interest Articles

General Interest Articles

1. Primary non-Hodgkin's lymphoma of bone in children.

Author: Glotzbecker MP; Kersun LS; Choi JK; Wills BP; Schaffer AA; Dormans JP;
Institution: The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Journal: J Bone Joint Surg Am. 2006 Mar;88(3):583-94.
Abstract URL: Click here to view abstract

2. Intraorbital lymphomas: neurosurgical experiences and management strategies.

Author: Hejazi N;
Institution: Department of Neurosurgery, LKH Feldkirch, Academic Hospital of the University of Innsbruck, Feldkirch, Austria. Hejazi@web.de
Journal: Neurosurg Rev. 2006 Apr;29(2):123-9. Epub 2006 Jan 6.
Abstract URL: Click here to view abstract

3. Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study.

Author: Mudie NY; Swerdlow AJ; Higgins CD; Smith P; Qiao Z; Hancock BW; Hoskin PJ; Linch DC; Mudie NY; Swerdlow AJ; Higgins CD; Smith P; Qiao Z; Hancock BW; Hoskin PJ; Linch DC;
Institution: Section of Epidemiology, Institute of Cancer Research, Sutton, Surrey, United Kingdom. nadejda.mudie@icr.ac.uk
Journal: J Clin Oncol. 2006 Apr 1;24(10):1568-74. Epub 2006 Mar 6.
Abstract URL: Click here to view abstract

4. Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology.

Author: Zelenetz AD; Advani RH; Buadi F; Cabanillas F; Caligiuri MA; Czuczman MS; Damon LE; Fayad L; Flinn IW; Forero A; Glenn MJ; Gockerman JP; Gordon LI; Harris NL; Hoppe RT; Kaminski MS; Lacasce AS; Nademanee A; Porcu P; Press O; Prosnitz L; Smith MR; Sotomayor EM; Vose JM; Yahalom J; Zelenetz AD; Advani RH; Buadi F; Cabanillas F; Caligiuri MA; Czuczman MS; Damon LE; Fayad L; Flinn IW; Forero A; Glenn MJ; Gockerman JP; Gordon LI; Harris NL; Hoppe RT; Kaminski MS; Lacasce AS; Nademanee A; Porcu P; Press O; Prosnitz L; Smith MR; Sotomayor EM; Vose JM; Yahalom J;
Institution
Journal: J Natl Compr Canc Netw. 2006 Mar;4(3):258-310.

5. Treatment and survival for non-Hodgkin's lymphoma: influence of histological subtype, age, and other factors in a population-based study (1999-2001).

Author: Cronin-Fenton DP; Sharp L; Deady S; Comber H;
Institution: National Cancer Registry of Ireland, Elm Court, Boreenmanna Road, Cork, Ireland. dc@dce.au.dk
Journal: Eur J Cancer. 2006 Nov;42(16):2786-93. Epub 2006 Aug 23.
Abstract URL: Click here to view abstract

6. Same day Pegfilgrastim and CHOP chemotherapy for non-Hodgkin lymphoma.

Author: Lokich JJ;
Institution: The Cancer Center of Boston, Chestnut Hill, MA, USA.
Journal: Am J Clin Oncol. 2006 Aug;29(4):361-3.
Abstract URL: Click here to view abstract

7. Clinical characteristics and treatment results of pediatric B-cell non-Hodgkin lymphoma patients in a single center.

Author: Karadeniz C; Oguz A; Citak EC; Uluoglu O; Okur V; Demirci S; Okur A; Aksakal N;
Institution: Gazi University Faculty of Medicine, Department of Pediatric Oncology, Ankara, Turkey.
Journal: Pediatr Hematol Oncol. 2007 Sep;24(6):417-30.
Abstract URL: Click here to view abstract

8. Elderly patients with non-Hodgkin lymphoma who receive chemotherapy are at higher risk for osteoporosis and fractures.

Author: Cabanillas ME; Lu H; Fang S; Du XL;
Institution: Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. mcabani@mdanderson.org
Journal: Leuk Lymphoma. 2007 Aug;48(8):1514-21.
Abstract URL: Click here to view abstract

9. Drug evaluation: FavId, a patient-specific idiotypic vaccine for non-Hodgkin's lymphoma.

Author: Reinis M;
Institution: Academy of Sciences of the Czech Republic, Institute of Molecular Genetics, Videnska 1083, Prague 4, CZ-14220, Czech Republic. reinis@img.cas.cz
Journal: Curr Opin Mol Ther. 2007 Jun;9(3):291-8.
Abstract URL: Click here to view abstract

10. Rapidly increasing incidence of ocular non-hodgkin lymphoma.

Author: Moslehi R; Devesa SS; Schairer C; Fraumeni JF Jr;
Institution: Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA. moslehir@mail.nih.gov
Journal: J Natl Cancer Inst. 2006 Jul 5;98(13):936-9.
Abstract URL: Click here to view abstract

11. Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute-Surveillance, Epidemiology, and End Results population-based case-control study.

Author: Kelemen LE; Cerhan JR; Lim U; Davis S; Cozen W; Schenk M; Colt J; Hartge P; Ward MH;
Institution: Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Journal: Am J Clin Nutr. 2006 Jun;83(6):1401-10.
Abstract URL: Click here to view abstract

12. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.

Author: Tward JD; Wendland MM; Shrieve DC; Szabo A; Gaffney DK; Tward JD; Wendland MM; Shrieve DC; Szabo A; Gaffney DK;
Institution: Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah 84112-5560, USA. jonathan.tward@hci.utah.edu
Journal: Cancer. 2006 Jul 1;107(1):108-15.
Abstract URL: Click here to view abstract

13. Primary bone lymphoma: a retrospective analysis.

Author: Horsman JM; Thomas J; Hough R; Hancock BW;
Institution: YCR Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield S10 2SJ, UK.
Journal: Int J Oncol. 2006 Jun;28(6):1571-5.
Abstract URL: Click here to view abstract

14. The role of surgical intervention in non-Hodgkin's lymphoma of the colon and rectum.

Author: Cai S; Cannizzo F Jr; Bullard Dunn KM; Gibbs JF; Czuczman M; Rajput A;
Institution: Department of Surgery, The State University of New York at Buffalo, Buffalo, NY, USA.
Journal: Am J Surg. 2007 Mar;193(3):409-12; discussion 412.
Abstract URL: Click here to view abstract

15. Revised response criteria for malignant lymphoma.

Author: Cheson BD; Pfistner B; Juweid ME; Gascoyne RD; Specht L; Horning SJ; Coiffier B; Fisher RI; Hagenbeek A; Zucca E; Rosen ST; Stroobants S; Lister TA; Hoppe RT; Dreyling M; Tobinai K; Vose JM; Connors JM; Federico M; Diehl V;
Institution: Division of Hematology/Oncology, Georgetown University Hospital, Washington, DC, USA. bdc4@georgetown.edu
Journal: J Clin Oncol. 2007 Feb 10;25(5):579-86. Epub 2007 Jan 22.
Abstract URL: Click here to view abstract

16. Rheumatic manifestations of lymphoproliferative disorders.

Author: Kiltz U; Brandt J; Zochling J; Braun J;
Institution: Rheumazentrum Ruhrgebiet, St. Josefs-Krankenhaus, Herne, Germany. kiltz@rheumazentrum-ruhrgbiet.de
Journal: Clin Exp Rheumatol. 2007 Jan-Feb;25(1):35-9.
Abstract URL: Click here to view abstract

17. The impact of involved field radiation therapy in the treatment of relapsed or refractory non-Hodgkin lymphoma with high-dose chemotherapy followed by hematopoietic progenitor cell transplant.

Author: Wendland MM; Smith DC; Boucher KM; Asch JD; Pulsipher MA; Thomson JW; Shrieve DC; Gaffney DK;
Institution: Department of Radiation Oncology, Huntsman Cancer Hospital and the University of Utah, Salt Lake City, Utah 84112, USA.
Journal: Am J Clin Oncol. 2007 Apr;30(2):156-62.
Abstract URL: Click here to view abstract

18. Non-Hodgkin's lymphoma incidence and survival in European children and adolescents (1978-1997): report from the Automated Childhood Cancer Information System project.

Author: Izarzugaza MI; Steliarova-Foucher E; Martos MC; Zivkovic S;
Institution: Basque Country Health Department, Registro de Cancer, Donostia-San Sebastian, 1. 01010 Vitoria-Gasteiz, Spain. info5-san@ej-gv.es
Journal: Eur J Cancer. 2006 Sep;42(13):2050-63.
Abstract URL: Click here to view abstract

19. Quality of life among long-term non-Hodgkin lymphoma survivors: a population-based study.

Author: Mols F; Aaronson NK; Vingerhoets AJ; Coebergh JW; Vreugdenhil G; Lybeert ML; van de Poll-Franse LV;
Institution: Comprehensive Cancer Center South, Eindhoven Cancer Registry, Eindhoven, the Netherlands. f.mols@uvt.nl
Journal: Cancer. 2007 Apr 15;109(8):1659-67.
Abstract URL: Click here to view abstract

20. Occupation and the risk of non-Hodgkin lymphoma.

Author: Boffetta P; de Vocht F;
Institution: Gene-Environment Epidemiology Group, IARC, 150 cours Albert-Thomas, 69008 Lyon, France. boffetta@iarc.fr
Journal: Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):369-72.
Abstract URL: Click here to view abstract

21. Immunogenicity of influenza vaccination in patients with non-hodgkin lymphoma.

Author: Centkowski P; Brydak L; Machala M; Kalinka-Warzocha E; Blasinska-Morawiec M; Federowicz I; Walewski J; Wc E Grzyn J; Wolowiec D; Lech-Maranda E; Sawczuk-Chabin J; Bilinski P; Warzocha K;
Institution: Department of Hematology, Institute of Hematology and Transfusion Medicine, I. Gandhi Street 14, 02776, Warsaw, Poland.
Journal: J Clin Immunol. 2007 May;27(3):339-46. Epub 2007 Mar 8.
Abstract URL: Click here to view abstract

22. Environmental and behavioral factors and the risk of non-Hodgkin lymphoma.

Author: Hartge P; Smith MT;
Institution: National Cancer Institute, NIH, Department of Health and Human Services, Rockville, MD 20892, USA. hartge@nih.gov
Journal: Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):367-8. Epub 2007 Mar 7.

23. Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.

Author: Moser EC; Noordijk EM; van Leeuwen FE; Baars JW; Thomas J; Carde P; Meerwaldt JH; van Glabbeke M; Kluin-Nelemans HC;
Institution: EORTC Data Centre, Brussels, Belgium. e.c.moser@lumc.nl
Journal: Haematologica. 2006 Nov;91(11):1481-8. Epub 2006 Oct 17.
Abstract URL: Click here to view abstract

24. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.

Author: Maule M; Scelo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P;
Institution: Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, CPO Piemonte, CeRMS, University of Turin, Via Santena 7, 10126, Turin, Italy. milena.maule@unito.it
Journal: J Natl Cancer Inst. 2007 May 16;99(10):790-800.
Abstract URL: Click here to view abstract

25. Obesity and risk of non-Hodgkin lymphoma (United States).

Author: Chiu BC; Soni L; Gapstur SM; Fought AJ; Evens AM; Weisenburger DD;
Institution: Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, 680 North Lake Shore Drive, Suite 1102, Chicago, IL, 60611-4402, USA.
Journal: Cancer Causes Control. 2007 May 7;.
Abstract URL: Click here to view abstract

26. Infectious complications of monoclonal antibodies used in cancer therapy: a systematic review of the evidence from randomized controlled trials.

Author: Rafailidis PI; Kakisi OK; Vardakas K; Falagas ME;
Institution: Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece.
Journal: Cancer. 2007 Apr 11;.
Abstract URL: Click here to view abstract

27. Long-term pulmonary function in survivors of childhood Hodgkin disease and non-Hodgkin lymphoma.

Author: Oguz A; Tayfun T; Citak EC; Karadeniz C; Tatlicioglu T; Boyunaga O; Bora H;
Institution: Department of Pediatric Oncology, Gazi University Faculty of Medicine, Ankara, Turkey.
Journal: Pediatr Blood Cancer. 2007 Apr 9;.
Abstract URL: Click here to view abstract

28. The role of FDG PET in the management of lymphoma: what is the evidence base?

Author: Kirby AM; Mikhaeel NG;
Institution: Department of Clinical Oncology, Guy's and St Thomas' NHS Trust, London, UK. annakirby@doctors.org.uk
Journal: Nucl Med Commun. 2007 May;28(5):335-54.
Abstract URL: Click here to view abstract

29. Predicting the outcome in non-Hodgkin lymphoma with molecular markers.

Author: Kwong YL;
Institution: Department of Medicine, University of Hong Kong, Hong Kong, China.
Journal: Br J Haematol. 2007 May;137(4):273-87. Epub 2007 Apr 4.
Abstract URL: Click here to view abstract

30. Survival from adolescent cancer.

Author: Desandes E;
Institution: French National Registry of Childhood Solid Tumours, Universite Henri Poincare Nancy 1, Faculte de Medecine, 9, Avenue de la Foret de Haye, BP 184, 54505 Vandoeuvre-les-Nancy cedex, France.
Journal: Cancer Treat Rev. 2007 Mar 28;.
Abstract URL: Click here to view abstract